Long Term Outcome of Combined Phacoemulsification and Excisional Goniotomy With the Kahook Dual Blade
1 other identifier
interventional
57
1 country
1
Brief Summary
Purpose: Characterize changes in intraocular pressure (IOP), IOP-lowering medications, and visual acuity (VA) through 3 years in patients undergoing combined phacoemulsification and excisional goniotomy with the Kahook Dual Blade (phaco-KDB), with simultaneous goniosynechialysis in cases of angle-closure glaucoma, by a single surgeon (A.H.) in King Fahd Hospital of the University, Dammam, Saudi Arabia. Methods: Prospective, non-comparative, uncontrolled, non-randomized interventional case series. Consecutive patients with medically-treated glaucoma and visually-significant cataract underwent combined surgery. Subgroup analysis of glaucoma subtypes was performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2020
CompletedFirst Submitted
Initial submission to the registry
July 10, 2020
CompletedFirst Posted
Study publicly available on registry
July 20, 2020
CompletedJuly 29, 2020
July 1, 2020
3.1 years
July 10, 2020
July 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Intraocular pressure
Characterize changes in intraocular pressure (IOP) in mmHg goldmann applanation tonometry each visit in the clinic after the combined phacoemulsification and excisional goniotomy with the kahook dual blade.
36 months
Intraocular pressure lowering medications
count the change in number of Intraocular pressure lowering medications each visit in the clinic after the combined phacoemulsification and excisional goniotomy with the kahook dual blade
36 months
Secondary Outcomes (1)
Visual acuity
36 months
Study Arms (1)
combined (phaco-kdb)
EXPERIMENTALProspective, non-comparative, uncontrolled, non-randomized interventional case series. Consecutive patients with medically-treated glaucoma and visually-significant cataract underwent combined surgery. Subgroup analysis of glaucoma subtypes was performed.
Interventions
Combined Phacoemulsification and Excisional Goniotomy with the Kahook Dual Blade
Eligibility Criteria
You may qualify if:
- adults 18 years or older
- medically-managed glaucoma
- visually significant cataract
You may not qualify if:
- Patients undergoing any other combined procedures
- active uveitis
- coexisting retinopathy that limits visual acuity potential
- active neovascularization
- angle dysgenesis
- those with less than 6 months of follow-up, were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ahmed Al Habashlead
Study Sites (1)
Imam Abdulrahman Bin Faisal University Hospital
Dammam, Saudi Arabia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed Al habash, MD
assistant professor
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr. Ahmed Al Habash, MD assistant professor, consultant cataract and glaucoma
Study Record Dates
First Submitted
July 10, 2020
First Posted
July 20, 2020
Study Start
January 1, 2017
Primary Completion
January 30, 2020
Study Completion
January 30, 2020
Last Updated
July 29, 2020
Record last verified: 2020-07